XML 221 R51.htm IDEA: XBRL DOCUMENT v2.4.0.8
Equity (Tables)
12 Months Ended
Dec. 31, 2013
Equity [Abstract]  
Schedule of Dividends Paid, Preferred Stock
Information on the declaration, record and payment dates, as well as per share and aggregate dividend amounts, for the Series A and Series B preferred shares was as follows:
 
 
 
 
 
 
Dividend
Declaration Date
 
Record Date
 
Payment Date
 
Series A
Per Share
 
Series A
Aggregate
 
Series B
Per Share
 
Series B
Aggregate
 
 
 
 
 
 
(In millions, except per share data)
November 15, 2013
 
November 30, 2013
 
December 16, 2013
 
$
0.253

 
$
7

 
$
0.406

 
$
24

August 15, 2013
 
August 31, 2013
 
September 16, 2013
 
$
0.256

 
6

 
$
0.406

 
24

May 15, 2013
 
May 31, 2013
 
June 17, 2013
 
$
0.256

 
7

 
$
0.406

 
24

March 5, 2013
 
February 28, 2013
 
March 15, 2013
 
$
0.250

 
6

 
$
0.406

 
24

 
 
 
 
 
 
 
 
$
26

 
 
 
$
96

November 15, 2012
 
November 30, 2012
 
December 17, 2012
 
$
0.253

 
$
7

 
$
0.406

 
$
24

August 15, 2012
 
August 31, 2012
 
September 17, 2012
 
$
0.256

 
6

 
$
0.406

 
24

May 15, 2012
 
May 31, 2012
 
June 15, 2012
 
$
0.256

 
7

 
$
0.406

 
24

March 5, 2012
 
February 29, 2012
 
March 15, 2012
 
$
0.253

 
6

 
$
0.406

 
24

 
 
 
 
 
 
 
 
$
26

 
 
 
$
96

November 15, 2011
 
November 30, 2011
 
December 15, 2011
 
$
0.253

 
$
7

 
$
0.406

 
$
24

August 15, 2011
 
August 31, 2011
 
September 15, 2011
 
$
0.256

 
6

 
$
0.406

 
24

May 16, 2011
 
May 31, 2011
 
June 15, 2011
 
$
0.256

 
7

 
$
0.406

 
24

March 7, 2011
 
February 28, 2011
 
March 15, 2011
 
$
0.250

 
6

 
$
0.406

 
24

 
 
 
 
 
 
 
 
$
26

 
 
 
$
96

Schedule of Dividends Paid, Common Stock
The table below presents declaration, record and payment dates, as well as per share and aggregate dividend amounts, for common stock:
 
 
 
 
 
 
Dividend
 Declaration Date
 
 Record Date
 
 Payment Date
 
Per Share
 
Aggregate

 

 

 
(In millions, except per share data)
October 22, 2013
 
November 8, 2013
 
December 13, 2013
 
$
0.275

 
$
311

June 25, 2013
 
August 9, 2013
 
September 13, 2013
 
$
0.275

 
303

April 23, 2013
 
May 9, 2013
 
June 13, 2013
 
$
0.275

 
302

January 4, 2013
 
February 6, 2013
 
March 13, 2013
 
$
0.185

 
203

 
 
 
 
 
 
 
 
$
1,119

 
 
 
 
 
 
 
 
 
October 23, 2012
 
November 9, 2012
 
December 14, 2012
 
$
0.740

 
$
811

October 25, 2011
 
November 9, 2011
 
December 14, 2011
 
$
0.740

 
$
787

Components of compensation expense related to stock based compensation
The components of compensation expense related to stock-based compensation includes compensation expense related to Phantom Stock-Based Awards, and excludes the insignificant compensation expense related to the 2005 Directors Stock Plan. Those components were:
 
Years Ended December 31,
 
2013
 
2012
 
2011
 
(In millions)
Stock Options and Unit Options
$
39

 
$
61

 
$
58

Performance Shares and Units (1)
91

 
80

 
68

Restricted Stock Units and Restricted Units
45

 
27

 
18

Total compensation expense
$
175

 
$
168

 
$
144

Income tax benefit
$
61

 
$
59

 
$
50

______________
(1)
Performance Shares expected to vest and the related compensation expenses may be further adjusted by the performance factor most likely to be achieved, as estimated by management, at the end of the performance period.
Total unrecognized compensation expense related to stock based compensation and the expected weighted average period over which the expenses will be recognized
The following table presents the total unrecognized compensation expense related to stock-based compensation and the expected weighted average period over which these expenses will be recognized at:
 
December 31, 2013
 
Expense
 
Weighted Average
Period
 
(In millions)
 
(Years)
Stock Options
$
25

 
1.27
Performance Shares
$
61

 
1.71
Restricted Stock Units
$
42

 
1.88
Activity related to Stock Options
A summary of the activity related to Stock Options was as follows:
 
Shares
Under
Option
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual
Term
 
Aggregate
Intrinsic
Value (1)
 
 
 
 

 
(Years)
 
(In millions)
Outstanding at January 1, 2013
35,153,071

 
$
40.89

 
5.50
 
$
51

Granted
1,310,019

 
$
35.96

 
 
 
 
Exercised
(6,357,522
)
 
$
31.80

 
 
 
 
Expired
(183,662
)
 
$
50.46

 
 
 
 
Forfeited
(170,530
)
 
$
39.86

 
 
 
 
Outstanding at December 31, 2013
29,751,376

 
$
42.56

 
5.19
 
$
379

Expected to vest at a future date as of December 31, 2013
29,536,674

 
$
42.60

 
5.16
 
$
376

Exercisable at December 31, 2013
22,786,277

 
$
43.56

 
4.32
 
$
277

______________
(1)
The aggregate intrinsic value was computed using the closing Share price on December 31, 2013 of $53.92 and December 31, 2012 of $32.94, as applicable.
Weighted average assumptions used to determine the fair value of Stock Options issued
The following table presents the weighted average assumptions, with the exception of risk-free rate, which is expressed as a range, used to determine the fair value of Stock Options issued:
 
Years Ended December 31,
 
2013
 
2012
 
2011
Dividend yield
2.13%
 
1.95%
 
1.65%
Risk-free rate of return
0.16%-3.89%
 
0.21%-4.17%
 
0.29%-5.51%
Expected volatility
32.98%
 
35.59%
 
32.64%
Exercise multiple
1.51
 
1.58
 
1.69
Post-vesting termination rate
3.16%
 
3.14%
 
3.36%
Contractual term (years)
10
 
10
 
10
Expected life (years)
7
 
7
 
7
Weighted average exercise price of stock options granted
$
35.96

 
$
37.91

 
$
45.16

Weighted average fair value of stock options granted
$
9.88

 
$
11.33

 
$
14.27

Stock Option exercise activity
The following table presents a summary of Stock Option exercise activity:
 
Years Ended December 31,
 
2013
 
2012
 
2011
 
(In millions)
Total intrinsic value of stock options exercised
$
79

 
$
29

 
$
41

Cash received from exercise of stock options
$
202

 
$
109

 
$
88

Income tax benefit realized from stock options exercised
$
28

 
$
10

 
$
14

Performance Share and Restricted Stock Unit Activity
The following table presents a summary of Performance Share and Restricted Stock Unit activity:
 
Performance Shares
 
Restricted Stock Units
 
Shares
 
Weighted
Average
Grant Date
Fair Value
 
Units
 
Weighted
Average
Grant Date
Fair Value
Outstanding at January 1, 2013
4,822,028

 
$
36.93

 
2,080,148

 
$
36.55

Granted
1,749,212

 
$
50.86

 
2,182,213

 
$
32.34

Forfeited
(151,075
)
 
$
40.87

 
(395,365
)
 
$
33.97

Payable (1)
(1,346,025
)
 
$
32.24

 
(538,480
)
 
$
33.17

Outstanding at December 31, 2013
5,074,140

 
$
42.86

 
3,328,516

 
$
33.35

Expected to vest at a future date as of December 31, 2013
5,067,337

 
$
38.60

 
2,995,664

 
$
33.34

______________
(1)
Includes both Shares paid and Shares deferred for later payment.
Liability Award Unit Activity
The following table presents a summary of Liability Awards activity:
 
Unit
Options
 
Restricted
Units
 
Performance
Units
Outstanding at January 1, 2013
1,370,317

 
740,436

 
305,164

Granted
48,301

 
445,740

 
297,834

Exercised
(127,386
)
 

 

Forfeited
(69,606
)
 
(127,329
)
 
(15,761
)
Paid

 
(79,325
)
 
(55,349
)
Outstanding at December 31, 2013
1,221,626

 
979,522

 
531,888

Expected to vest at a future date as of December 31, 2013
1,137,832

 
881,570

 
478,699

Schedules of statutory net income, and capital and surplus by subsidiary
Statutory net income (loss) was as follows:
 
 
 
 
Years Ended December 31,
Company
 
State of Domicile
 
2013
 
2012
 
2011
 
 
 
 
(In millions)
Metropolitan Life Insurance Company
 
New York
 
$
369

 
$
1,320

 
$
1,970

American Life Insurance Company
 
Delaware
 
$
631

 
$
317

 
$
334

MetLife Insurance Company of Connecticut
 
Connecticut
 
$
790

 
$
848

 
$
46

Metropolitan Property and Casualty Insurance Company
 
Rhode Island
 
$
282

 
$
235

 
$
41

Metropolitan Tower Life Insurance Company
 
Delaware
 
$
52

 
$
61

 
$
63

Statutory capital and surplus was as follows at:
 
 
December 31,
Company
 
2013
 
2012
 
 
(In millions)
Metropolitan Life Insurance Company
 
$
12,428

 
$
14,295

American Life Insurance Company
 
$
2,711

 
$
3,044

MetLife Insurance Company of Connecticut
 
$
4,795

 
$
5,331

Metropolitan Property and Casualty Insurance Company
 
$
2,225

 
$
1,987

Metropolitan Tower Life Insurance Company
 
$
735

 
$
781

Dividend Payment Restrictions
The table below sets forth the dividends permitted to be paid by the respective insurance subsidiary without insurance regulatory approval and the respective dividends paid:
 
 
2014
 
2013
 
2012
Company
 
Permitted w/o
Approval (1)
 
Paid (2)
 
Permitted w/o
Approval (3)
 
Paid (2)
 
Permitted w/o
Approval (3)
 
 
(In millions)
Metropolitan Life Insurance Company
 
$
1,116

 
$
1,428

 
$
1,428

 
$
1,023


$
1,350

American Life Insurance Company
 
$

 
$

 
$
523

 
$
1,300

(4)
$
168

MetLife Insurance Company of Connecticut
 
$
1,061

 
$
1,000

 
$
1,330

 
$
706

(5)
$
504

Metropolitan Property and Casualty Insurance Company
 
$
218

 
$
100

 
$
74

 
$
100

 
$

Metropolitan Tower Life Insurance Company
 
$
73

 
$
109

(6
)
$
77

 
$
82

 
$
82

MetLife Investors Insurance Company
 
$
99

 
$
129

 
$
129

 
$
18

 
$
18

Delaware American Life Insurance Company
 
$
16

 
$

 
$
7

 
$

 
$
12

______________
(1)
Reflects dividend amounts that may be paid during 2014 without prior regulatory approval. However, because dividend tests may be based on dividends previously paid over rolling 12-month periods, if paid before a specified date during 2014, some or all of such dividends may require regulatory approval.
(2)
Reflects all amounts paid, including those requiring regulatory approval.
(3)
Reflects dividend amounts that could have been paid during the relevant year without prior regulatory approval.
(4)
During May 2012, American Life received regulatory approval to pay an extraordinary dividend for an amount up to the funds remitted in connection with the restructuring of American Life’s business in Japan. Subsequently, $1.5 billion was remitted to American Life. See Note 3. Of this approved amount, $1.3 billion was paid to MetLife, Inc. as an extraordinary dividend.
(5)
During June 2012, MICC distributed shares of an affiliate to its stockholders as an in-kind extraordinary dividend of $202 million as calculated on a statutory basis. Regulatory approval for this extraordinary dividend was obtained due to the timing of payment. During December 2012, MICC paid a dividend to its stockholders in the amount of $504 million, which represented its ordinary dividend capacity at December 31, 2012. Due to the June 2012 in-kind dividend, a portion of this was extraordinary and regulatory approval was obtained.
(6)
During October 2013, Metropolitan Tower Life Insurance Company (“MTL”) distributed shares of an affiliate to MetLife, Inc. as an in-kind dividend of $32 million. Also during October 2013, MTL paid a dividend to MetLife, Inc. in the amount of $77 million in cash, which represented its dividend capacity without regulatory approval at December 31, 2013. Regulatory approval for these dividends was obtained due to the amount and timing of the payments.
Components of Accumulated Other Comprehensive Income (Loss)
Information regarding changes in the balances of each component of AOCI attributable to MetLife, Inc., net of income tax, was as follows:

 
Unrealized
Investment Gains
(Losses), Net of
Related Offsets (1)
 
Unrealized
Gains (Losses)
on Derivatives
 
Foreign
Currency
Translation
Adjustments
 
Defined
Benefit
Plans
Adjustment
 
Total
 
(In millions)
Balance at December 31, 2010
$
3,161

 
$
(39
)
 
$
(528
)
 
$
(1,449
)
 
$
1,145

OCI before reclassifications
7,637

 
1,595

 
42

 
(893
)
 
8,381

Income tax expense (benefit)
(2,604
)
 
(557
)
 
(162
)
 
312

 
(3,011
)
OCI before reclassifications, net of income tax
8,194

 
999

 
(648
)
 
(2,030
)
 
6,515

Amounts reclassified from AOCI
(766
)
 
(21
)
 

 
133

 
(654
)
Income tax expense (benefit)
261

 
7

 

 
(46
)
 
222

Amounts reclassified from AOCI, net of income tax
(505
)
 
(14
)
 

 
87

 
(432
)
Balance at December 31, 2011
7,689

 
985

 
(648
)
 
(1,943
)
 
6,083

OCI before reclassifications
9,321

 
(262
)
 
(134
)
 
(996
)
 
7,929

Income tax expense (benefit)
(3,457
)
 
92

 
249

 
350

 
(2,766
)
OCI before reclassifications, net of income tax
13,553

 
815

 
(533
)
 
(2,589
)
 
11,246

Amounts reclassified from AOCI
58

 
24

 

 
154

 
236

Income tax expense (benefit)
(23
)
 
(8
)
 

 
(54
)
 
(85
)
Amounts reclassified from AOCI, net of income tax
35

 
16

 

 
100

 
151

Balance at December 31, 2012
13,588

 
831

 
(533
)
 
(2,489
)
 
11,397

OCI before reclassifications
(8,487
)
 
(937
)
 
(937
)
 
1,078

 
(9,283
)
Income tax expense (benefit)
2,807

 
312

 
(189
)
 
(379
)
 
2,551

OCI before reclassifications, net of income tax
7,908

 
206

 
(1,659
)
 
(1,790
)
 
4,665

Amounts reclassified from AOCI
411

 
36

 

 
214

 
661

Income tax expense (benefit)
(136
)
 
(11
)
 

 
(75
)
 
(222
)
Amounts reclassified from AOCI, net of income tax
275

 
25

 

 
139

 
439

Balance at December 31, 2013
$
8,183

 
$
231

 
$
(1,659
)
 
$
(1,651
)
 
$
5,104

__________________
(1)
See Note 8 for information on offsets to investments related to insurance liabilities, DAC and VOBA and the policyholder dividend obligation.
Reclassification out of Accumulated Other Comprehensive Income (Loss)
Information regarding amounts reclassified out of each component of AOCI, was as follows:

AOCI Components
 
Amounts Reclassified from AOCI
 
Statement of Operations and
Comprehensive Income (Loss) Location
 
 
Years Ended December 31,
 
 
 
 
2013
 
2012
 
2011
 
 
 
 
(In millions)
 
 
Net unrealized investment gains (losses):
 
 
 
 
 
 
 
 
Net unrealized investment gains (losses)
 
$
404

 
$
(34
)
 
$
(952
)
 
Other net investment gains (losses)
Net unrealized investment gains (losses)
 
93

 
73

 
73

 
Net investment income
Net unrealized investment gains (losses)
 
(26
)
 
(10
)
 
144

 
Net derivative gains (losses)
OTTI
 
(60
)
 
29

 
(31
)
 
OTTI on fixed maturity securities
Net unrealized investment gains (losses), before income tax
 
411

 
58

 
(766
)
 
 
Income tax (expense) benefit
 
(136
)
 
(23
)
 
261

 
 
Net unrealized investment gains (losses), net of income tax
 
$
275

 
$
35

 
$
(505
)
 
 
Unrealized gains (losses) on derivatives - cash flow hedges:
 
 
 
 
 
 
 
 
Interest rate swaps
 
$
20

 
$
1

 
$
(42
)
 
Net derivative gains (losses)
Interest rate swaps
 
8

 
4

 
1

 
Net investment income
Interest rate swaps
 

 
(3
)
 
(10
)
 
Other expenses
Interest rate forwards
 
10

 
1

 
31

 
Net derivative gains (losses)
Interest rate forwards
 
3

 
2

 
1

 
Net investment income
Interest rate forwards
 
(1
)
 
(1
)
 
(1
)
 
Other expenses
Foreign currency swaps
 
(3
)
 
23

 

 
Net derivative gains (losses)
Foreign currency swaps
 
(3
)
 
(5
)
 
(6
)
 
Net investment income
Foreign currency swaps
 
1

 
1

 
2

 
Other expenses
Credit forwards
 

 

 
2

 
Net derivative gains (losses)
Credit forwards
 
1

 
1

 
1

 
Net investment income
Gains (losses) on cash flow hedges, before income tax
 
36

 
24

 
(21
)
 
 
Income tax (expense) benefit
 
(11
)
 
(8
)
 
7

 
 
Gains (losses) on cash flow hedges, net of income tax
 
$
25

 
$
16

 
$
(14
)
 
 
 
 
 
 
 
 
 
 
 
Defined benefit plans adjustment: (1)
 
 
 
 
 
 
 
 
Amortization of net actuarial gains (losses)
 
$
283

 
$
252

 
$
237

 
 
Amortization of prior service (costs) credit
 
(69
)
 
(98
)
 
(104
)
 
 
Amortization of defined benefit plan items, before
 income tax
 
214

 
154

 
133

 
 
Income tax (expense) benefit
 
(75
)
 
(54
)
 
(46
)
 
 
Amortization of defined benefit plan items, net of income tax
 
$
139

 
$
100

 
$
87

 
 
Total reclassifications, net of income tax
 
$
439

 
$
151

 
$
(432
)
 
 
__________________

(1)
These AOCI components are included in the computation of net periodic benefit costs. See Note 18.